Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2023-04-06 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
2022年度独立董事述职报告
Board/Management Information Classification · 95% confidence The document is titled as the "2022年度独立董事述职报告" which translates to "2022 Annual Independent Directors' Report". It details the independent directors' activities, their attendance, opinions on company operations, compliance with laws and regulations, internal control, and governance matters for the year 2022. It includes detailed descriptions of their duties, evaluations, and suggestions for the company. The content is focused on management and board oversight rather than financial results or audit opinions. It is not a full annual report (10-K), audit report (AR), or earnings release (ER). It is a management-related report specifically from independent directors about their duties and governance oversight. Therefore, the best fitting category is Board/Management Information (MANG). The document length (5771 characters) and detailed content support this classification with high confidence.
2023-04-06 Chinese
2022年年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the use and management of funds raised through a public stock issuance by Shenzhen Huitai Medical Devices Co., Ltd. It includes specifics on the amount raised, fees paid, net proceeds, usage of funds, management systems, bank accounts, investment products, and changes to investment projects. The document references regulatory approvals and compliance with securities laws and stock exchange rules. It is not a general annual report or earnings release but a specialized report focused on the storage and actual use of raised funds. This matches the description of a Capital/Financing Update, which covers fundraising and capital structure changes. The document length is substantial and contains detailed financial data related to fundraising usage, not just an announcement or summary. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2023-04-06 Chinese
2022年度董事会审计委员会履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2022年度董事会审计委员会履职情况报告" which translates to "2022 Board Audit Committee Performance Report." It details the activities, meetings, and evaluations conducted by the audit committee during the year 2022, including oversight of external auditors, internal audit guidance, review of financial reports, and internal control assessments. The document is a report on the audit committee's duties and performance rather than a standalone audit report or full annual report. It does not contain full financial statements or detailed audit opinions but rather a summary of the committee's work and evaluations. This fits the category of an Audit Report / Information (AR), which includes reports on audit committee activities and audit-related oversight without being the full annual report or standalone audit opinion document. The document length is under 5,000 characters but contains substantive content, so it is not merely an announcement or certification. Therefore, the best classification is AR with high confidence. FY 2022
2023-04-06 Chinese
独立董事关于第二届董事会第三次会议相关议案的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion statement from independent directors regarding various proposals discussed at the second board meeting of Shenzhen Huitai Medical Devices Co., Ltd. The content includes opinions on profit distribution plans, internal control evaluation reports, use of idle funds, appointment of accounting firms, remuneration plans, fundraising usage reports, insurance for directors and supervisors, and investment project adjustments. The document is a formal opinion on board meeting agenda items rather than a full financial report or earnings release. It is not a transcript, capital update, or regulatory filing. The document length is 2817 characters, which is relatively short and focused on board meeting related opinions. This fits best under Board/Management Information (MANG) as it relates to board meeting proposals and independent directors' opinions on them.
2023-04-06 Chinese
独立董事对公司对外担保情况的专项说明
Audit Report / Information Classification · 95% confidence The document is a special statement by independent directors regarding the company's external guarantees during the 2022 reporting period. It references regulatory requirements from the China Securities Regulatory Commission and provides an independent opinion on the external guarantee situation. The document is short (732 characters) and focuses on a specific compliance and assurance matter rather than presenting full financial data or audit results. It is not an annual report, audit report, or financial statement. Instead, it is a standalone audit-related statement or assurance report by independent directors on a specific issue (external guarantees). This fits best under Audit Report / Information (AR), which includes standalone audit reports and related assurance statements. The document is not merely an announcement or certification but a substantive independent opinion on a regulatory compliance matter. Therefore, the classification is AR with high confidence. FY 2022
2023-04-06 Chinese
立信会计师事务所（特殊普通合伙）关于深圳惠泰医疗器械股份有限公司非经营性资金占用及其他关联资金往来情况汇总表的专项审计报告
Audit Report / Information Classification · 95% confidence The document is a specialized audit report titled "专项审计报告" (Special Audit Report) concerning non-operating fund occupation and other related party fund transactions for Shenzhen Huitai Medical Device Co., Ltd. for the fiscal year 2022. It includes detailed tables summarizing these transactions and is issued by an audit firm with a formal audit opinion. The document is about a specific audit on related party transactions and fund usage, not a full annual report or interim financial report. It is not a mere announcement or certification but contains substantive audit findings and data. Therefore, it fits the category of an Audit Report / Information (AR). The document length (11,865 characters) supports it being a full report rather than a brief announcement. Hence, the classification is AR with high confidence. FY 2022
2023-04-06 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.